MEET THE EXECUTIVE GUEST EDITORS

Prof. Abrahamse is presently serving as a Director in the Laser Research Center. She has been awarded a degree of PhD in Molecular Biology/Biochemistry from Wits University. Her research interests include photobiology and photochemistry with specific reference to photodynamic cancer therapy, nanotechnology and targeted cancer therapy investigating the intricate mechanisms underlying cancer cell death induced by novel photochemotherapeutic compounds in conjunction with the use of nanoparticles. Her international standing as a researcher of distinction is supported by the fact that she has hosted 3 international conferences and has been invited to present her research at several international conferences. Her publication record is impressive with 154 peer-reviewed accredited journal publications, 19 chapters and 3 books, and a Scopus H-index of 27.

Dr. DANCIU CORINA is a Researcher, Pharmacist and the Head of Department of Pharmacognosy in Victor Babes University of Medicine and Pharmacy Timisoara. She has been awarded a degree of PhD in 2013. She has contributed her valuable 60 publications in different scientific journals. She is also a member of the editorial board of 6 international journals and co-author of patents. Her research interests include: quantitative and qualitative characterization of vegetal extracts, in vitro and in vivo evaluation of pure natural compounds or total extracts for different types of cancer, anti-inflammatory, antioxidant and antibacterial effect.

Dr. Tânia Morais has been awarded a degree of PhD in Inorganic Chemistry in 2013 from the University of Lisbon. She was honored by the Portuguese Chemical Society in 2014 with the prize “Portuguese Young Chemist Award”. Currently, she is a researcher at Centro de Química Estrutural(CQE) at Faculdade de Ciências da Universidade de Lisboa (FCUL). Her research focuses on the design, synthesis and characterization of Ru, Fe and Cu complexes with targeting molecules (e.g. peptides, carbohydrates, and biomolecules) in their structure for the selective inhibition of the cancer development and metastases. She has 23 papers published in international journals, 3 book chapters and 3 patents.

Dr. Palmiro Poltronieri is presently serving as a researcher at the Agrofood Department of the Italian National Research Council. He holds a Ph.D. in Molecular and Cellular Biology from Verona University. His research interests include abiotic and biotic stress response in model plants, in bioactives from plants with a beneficial effect on health, in food microbiology and in the application of biocontrol strains for plant health. He is the co-founder of Biotecgen, a Small Medium Enterprise and service company, involved in European projects, such as RIBOREG, NANOMYC, ABSTRESS, and TOMGEM. He is Associate Editor to BMC Research Notes and is editor-in-chief for Challenges, an MDPI journal. He has co-authored 76 publications in international journals, 35 book chapters, and 5 books.

Dr. Nazma N. Inamdar is presently working as a Professor in the Government College of Pharmacy, Amravati, India. She is also engaged in the development of biomaterials, especially the chemically modified carbohydrates and their application in drug delivery systems for confined targets. She is also reviewing research articles as well as book chapters. She has authored the reference book ‘Comprehensive Chemistry and Biomedical Applications of Chitosan and Chemically Engineered Chitosans’. She has contributed her publications in different journals, having citations around 1, 358.

Dr. Jyotsana R. Madan is presently serving as a Professor and Head of the Department of Pharmaceutics at mt. Kashibai Navale College of Pharmacy affiliated to Savitribai Phule Pune University (SPPU), Pune, India. She has a rich experience of over 22 years comprising both teaching and research. Her main research interests focus on solubility enhancement of poorly water-soluble drugs using solid dispersions, molecular inclusion complexes, co-crystals and salt-forming techniques. She is also actively working in the area of diverse nanostructured drug delivery systems viz., polymeric micelles, liposomes proniosomes and mesoporous silica nanoparticles. She has authored over 35 publications in various peer reviewed journals.

Dr. Ingles is presently serving as a Professor of Educational Psychology at the Department of Health Psychology in the Miguel Hernandez University of Elche. He was awarded a degree of PhD in Clinical and Adolescent Psychology from the University of Murcia in 2001. He also received Extraordinary Doctorate Award for his Ph.D. from the UMU in 2004. He has contributed more than 180 articles in different Psychology Journals. His research interests include assessment, measurement, prevention, psychoeducational treatment on social anxiety, aggressive and prosocial behavior, legal drugs abuse, cognitive-motivational variables, academic achievement, perfectionism, school refusal behavior and positive and negative affect in children and adolescents.

Dr. Inamuddin is currently working as an Assistant Professor in Chemistry Department, Faculty of Science, King Abdulaziz University, Jeddah, Saudi Arabia. He has extensive research experience in multidisciplinary fields of Analytical Chemistry, Materials Chemistry and Electrochemistry. He has published 127 research articles in international journals of repute and 18 book chapters in knowledge-based book editions. He has published thirty-seven edited books for leading international publishers. He is serving as an Associate Editor for journals such as Environmental Chemistry Letter, Applied Water Science, Euro-Mediterranean Journal for Environmental Integration, Editorial Board Member for Scientific Reports-Nature and editor for Eurasian Journal of Analytical Chemistry.

Dr. Sevinc Kurbanoglu obtained PhD in Analytical Chemistry from Ankara University, Faculty of Pharmacy, Department of Analytical Chemistry, Nano bioelectronics & Biosensor Group at Institute Catala, Barcelona, Spain. She has been serving as a Research and Teaching Assistant Chemistry, Ankara, Turkey. She has contributed her valuable publications in different journals. Her skills and expertise are in Polymerization Materials, Nanomaterials, Polymers, Enzymes, Sample Preparation, Biomaterials, Nanoscience, High-Performance Liquid Chromatography and Chromatography.

Dr. Mashallah Rezakazemi received his B.Sc. and M. Sc. degrees in 2009 and 2011 respectively from the Iran University of Science and Technology. He has also been awarded a degree of PhD from the University of Tehran in 2015. Dr. Rezakazmi served as a professor of the faculty of Chemical and Material Engineering at the Shahrood University of Technology. His research interest is in the general area of the water-energy nexus, CO2 capture, gas separation, desalination, to the service of the broad areas of learning and training.

Dr. Samanidou is presently serving as a full professor at the University of Thessaloniki. She has been awarded a degree of PhD in Chemistry from the Aristotle University of Thessaloniki, Greece. She has published more than 130 original research articles in peer reviewed journals and 50 reviews and chapters in scientific books. She was also guest editor in 2 special issues in scientific journals. She is a member of the editorial board of more than 10 scientific journals and she has reviewed almost 400 manuscripts in more than 90 scientific journals.

Dr. Malek Hassanpour holds his M.Sc. degree in Environmental Health Engineering from Tehran University of Medical Sciences, Iran, and is currently a Ph.D. researcher in Environmental Science at Osmania University, India. His particular research focus is on Environmental Impact Assessment (EIA), waste management and plasma technology. His skills and expertise are in Renewable Energy Technologies, Water Quality, Environment, Economic Development, Sustainable Development, Environmental Analysis, Environmental Impact Assessment, Management, Business and Sustainability.

Dr. Shahram Javadi is presently serving as an Associate Professor of Electrical Engineering Department in I.A.U central Tehran. He is a senior member of IEEE and he is also an active researcher in Renewable Energies, smart grid, Electric Vehicles, Power electronics and control systems. He has contributed more than 100 papers in international journals and conferences. He is also a member of International and technical committee of WSEAS,IEEE, CIGRE Academic board for International Power System Conference (PSC), Academic board for Power System Protection & Control conference (PSPC), Member of Iranian Association of Electrical & Electronics Engineers (IAEEE), Member of the Scientific Committee of Iranian Wind Energy Society and Member of Iranian Fuzzy Systems Society.

Dr. Dengwei Jing is presently serving as a full time professor at the International Research Center for renewable Energy & National Laboratory of Multiphase flow in power engineering, Xi’an Jaitong University. He has been awarded a degree of PhD in Thermal Engineering from the same University in 2007. His field of expertise is in the Multiphase flow modelling and measurement, Solar Energy conversion, Hydrogen production and advanced nanotechnologies for enhanced heat and mass transfer. He has also been awarded as the Newton Advanced Fellowship from the Royal Society, UK. He has published more than 115 peer reviewed journal papers, including Nature Communications, Renewable Energy and Sustainable Energy Reviews, Applied Physics Letters, Physics Fluids, AIChE J, Energy, Solar Energy, Inter J Heat Mass Transfer, etc.

Dr. Q. Li is currently serving as an Associate Researcher Professor in the Department of Energy and Power Engineering at Tsinghua University. He received his Doctoral, Master and Bachelor degree from the department of Thermal Engineering, Tsinghua University, China. He is a co-author of 180 peer reviewed articles and several book chapters and his H index is 20. His research interests include photothermic/voltaic hybrid solar energy utilization, industrial boiler design, biomass and waste combustion, environmental technology, et al.

Dr. E.A Parlak is presently serving as a senior scientist at TUBITAK Marmara Research Center Chemistry Institute. She completed her graduation from Middle East Technical University in 1997 and she further obtained M. Sc. Degree from the same institution. She has also been awarded a degree of PhD in 2006 from İstanbul Technical University (İTU) Polymer and Technology Programme. Her experience is mainly based on conducting polymers, organic photovoltaics, perovskite solar cells, and polymer technology. She has 30 publications in journal papers and participated in various national/international research projects on energy issues. She has participated in an international project that was COST 1307 International Project called ‘’ Stable next generation solar cells’’ In the project, we mostly motivated on stability protocols of organic and perovskite solar cells (ISOS stability protocols).

Dr. F. Jiang is presently serving as a professor in the Department of Physics from Jiangxi Science and Technology Normal University. He has been awarded a degree of PhD in Physical Chemistry in 2013 from Soochow University. His research interests lie in Organic film/fiber material including conducting polymer, graphene, and organic/inorganic hybrids in the field of organic thermoelectric. He has contributed his valuable publications in different scientific journals.

Dr. Huafeng Wei is an Associate Professor with Tenure at the Department of Anesthesiology at the University of Pennsylvania in the U.S.A. Dr. Wei completed his medical graduate student education and training in Anesthesiology at Tongji Medical University in 1988. He obtained his Ph.D. in pharmacology and toxicology from the George Washington University in 1996 and completed his postdoctoral training at Georgetown University and National Institute of Health (NIH) in 1999. He completed his second resident training in Anesthesiology and Critical Care at the University of Pennsylvania in 2003 and become a standing faculty member thereafter at UPENN. His lab has focused on studying the role of calcium dysregulation in neurodegeneration in various neurodegenerative diseases, especially in Alzheimer’s disease and after various general anesthetics treatments. His lab is the first to demonstrate that dantrolene, a drug for treatment of malignant hyperthermia, can abolish the memory and learning impairment in various animal models of Alzheimer’s disease. Dr. Wei has been an invited speaker for Harvard, Johns Hopkins, UCSF, Duke, UVA, Imperial College of England, University of Heidelberg in Germany, University of Padova in Italy, as well as speakers for international conferences in more than 10 countries and regions.

Prof. Shengzhou Wu received a degree of bachelor of Medicine from Shanghai Medical University (renamed as Shanghai Medical College of Fudan University in 2000) and obtained a Ph.D degree in Neuroscience from University of Arkansas for Medical Science. After a postdoctoral fellowship in Department of Neurology in Washington University School of Medicine in St Louis he has joined and currently is a professor in School of Optometry and Ophthalmology, Wenzhou Medical University in China. His major scientific interest is focused on neurodegeneration in the central nervous system and in the retina including Alzheimer's disease.

Dr. Chen received Ph.D. degree in System Analysis and Integration from East China Normal University, Shanghai. Currently, he is an associated professor in College of Information Engineering, Shanghai Maritime University. Dr. Chen is in charge of the academic degree of Software & Theory of Computer. His interests include bioinformatics, computational biology, machine learning, graph theory, and algorithm design. Up to now, he has published more than 90 scientific publications.

Dr. Yongqing Zhang is an Associate Professor in the School of Computer Science, Chengdu University of Information and Technology, Chengdu, China. He has been awarded a degree of PhD in Computer Science from Sichuan University, China in 2016. He was a visiting PhD student at the University of California San Diego, USA. His research is in the areas of machine learning and bioinformatics and his several related works have been published by NAR, EAAI, CHEMOMETER LAB, etc.

Dr. Heiko Konig is presently serving as an Assistant Professor at the Indiana University Melvin & Bren Simon Cancer Center in Inianapolis where his effort is dedicated to the care of patients with acute myeloid leukemia (AML) and other hematological malignancies, and laboratory based research with a focus on the role of hypoxia in the development of AML drug resistance and minimal residual disease. He received his MD and doctoral degrees from the medical schools at the Ludwig Maximilians University Munich and the Philipps University Marburg/ Germany, respectively. He is also serving as the co-chair of the Big Ten Cancer Research Consortium (BTCRC) Myeloid Malignancies Clinical Trial Working Group and the Hoosier Cancer Research Network (HCRN) Lymphoma/Leukemia Clinical Trial Working Group.

Dr. Guangwei Liu is currently serving as a professor in the Key Laboratory of Cell Proliferation and Regulation, Ministry of Education, Beijing Normal University, Beijing, China. He and his group members are currently interested in understanding the molecular and cellular mechanisms for positive and negative regulation of T cell immune function, exploring the possibility for clinical application of anti-tumor immunotherapy and anti-infection, as well as establishing protocols to induce transplant immune tolerance. He has contributed more than 70 peer reviewed papers in international journals such as Immunity, Nature Immunology, Nature Communications, PNAS, Blood, Journal of Immunology and Cancer Research.

Dr.Valery V. Tuchin is presently serving as a Professor and Chair of Optics and Biophotonics at Saratov University (National Research University of Russia). He is also the head of Laboratory of Laser Diagnostics of Technical and Living Systems, Institute of Precision Mechanics and Control, RAS, and the supervisor of Interdisciplinary Laboratory of Biophotonics at Tomsk State University (National Research University of Russia) and Laboratory of FemtoMedicine of ITMO University (National Research University of Russia). His research interests include tissue optics, laser medicine, tissue optical clearing, and nanobiophotonics. He has published more than 700 papers (Web of Science), 27 monographs and text-books, and 58 book chapters. Dr. Tuchin is also a holder of more than 50 patents.

Dr. Hui Ding is presently serving as an Associate Professor of Center for Informational Biology at the University of Electronic Science and Technology of China. She has been awarded a degree of PhD from Inner Mongolia University, China in 2009. Her research areas are of Systems Biology and theoretical Biology. She has contributed over 60 peer reviewed paper in SCI- indexed Journals. Her publications have been cited over 3, 406 times with H- index of 31 in google scholar.

Dr. Sevinc Kurbanoglu obtained PhD in Analytical Chemistry from Ankara University, Faculty of Pharmacy, Department of Analytical Chemistry, Nano bioelectronics & Biosensor Group at Institute Catala, Barcelona, Spain. She has been serving as a Research and Teaching Assistant Chemistry, Ankara, Turkey. She has contributed her valuable publications in different journals. Her skills and expertise are in Polymerization Materials, Nanomaterials, Polymers, Enzymes, Sample Preparation, Biomaterials, Nanoscience, High-Performance Liquid Chromatography and Chromatography.

Dr. Yujing Li is presently serving as a faculty member at the Department of Human Genetics, Emory University School of Medicine. He has been awarded a degree of PhD in Genetics from Institute of Genetics and Development Biology, Chinese Academy of Science, Beijing, China. He shares one patent with Dr. Richard B. Meagher. He serves as editorial board members / guest editor for several JCR journals as well as reviewers for many journals. He has authored 70 of peer reviewed papers and several book chapters. His research interests include cell biology, molecular genetics, genomics, neuroscience, epigenetics, and chemical biology and stem cells.

Dr. Bijo Mathew is presently working as an Associate Professor in Ahalia School of Pharmacy, Kerala, India and he has also been working on the screening of Novel Inhibitors of Monomine Oxidases and Cholinesterases from synthetic compounds to pursue pharmaceutical agents. He has been awarded a degree of PhD from Jawaharlal Nehru Technological University (JNTU) Hyderabad, India in 2016. He has contributed 80 research articles in qualified international journals with H index of 15.

Dr. Tarek A. Mohamed is presently serving as a full Professor in the Chemistry Department at Al-Azhar University. He has been awarded a degree of PhD in Chemistry through a joint program between the Chemistry Departments at the USC and UMass (USA) with Al-Azhar University (Egypt). He previously served at United Arab Emirates University (UAE), Sultan Qaboos University (Oman) and University of Nizwa (Oman). Dr. Mohamed has already authored/co-authored over 55 published manuscripts in refereed ISI international journals. Furthermore, he is a reviewer in 13 ISI-international journals, and he is also a Technical Program Committee (TPC) member of many international conferences.

Dr. Quan Zou is presently serving as a Professor in the Institute of Fundamental and Frontier Sciences, University of Electronic Science and Technology of China. He completed his B.Sc. and M. Sc. In Computer Science from Harbin Institute of Technology, China in 2004 and 2007. He has been awarded a degree of PhD in the same field from the same institution in 2009. He is a Senior Member of IEEE and ACM. He worked at Xiamen University and Tianjin University from 2009 to 2018 as an assistant professor, associate professor and professor. His research is in the areas of bioinformatics, machine learning and parallel computing. Several related works have been published by Science, Briefings in Bioinformatics, Bioinformatics, IEEE/ACM Transactions on Computational Biology and Bioinformatics, etc. Google scholar showed that his more than 100 papers have been cited more than 5000 times.

Dr Pupalan Iyngkaran is a qualified Cardiologist and subspecialist in Echocardiology, Cardiac Imaging Heart Failure at HeartWest, St Vincents and Western Private Hospitals. He is Senior Lecturer at Flinders University (Northern Territory Medical School) and Notre Dame University (Melbourne Medical School). Dr Iyngkaran has won independent medical grants from government and private bodies for works in cardiac imaging and heart failure. His research interests are aligned towards improving heart failure outcomes using epidemiological and imaging methods. He also collaborates with basic researches in this area.

Dr. Jing-an Li is a professor of Zhengzhou University, China, and his research filed include: Drug delivery and biomaterials. So far, he has published more than 40 academic papers on international academic journals as the first author or corresponding author, including ACS Applied Materials & Interface, Applied Surface Science, Biomaterials Science, and Journal of Materials Chemistry B. He has been serving as the editorial board member of repute journals, such as Current Chinese Biotechnology (Section Editor), Recent Patents on Nanotechnology, Biomed Research International (Lead Guest Editor), Genetics and Molecular Research, Current Drug Delivery (Executive Guest Editor). He was also honored with repute awards, such as “China-Korea Young Scientist Award”, “IAAM Scientist Award”, “IAAM Medal”, and “Outstanding Reviewer Award” of repute journals. Detail information please see: Researchgate: https://www.researchgate.net/profile/Jingan_Li2

Dr. Ayhan SAVASER graduated from Hacettepe University Faculty of Pharmacy in 1988, He received his M.Sc. degree in Pharmaceutical Technology with his thesis on ‘The Studies iNH tablets available on the Turkish drug market’’ in Gulhane Mİlitary Medical Academy. He obtained his Ph.D. degree with ‘‘The Development, in vitro evaluation and bioequivalence of sustained release tablet formulations of diclofenac sodium’’ thesis same Academy in 1999. He worked as assistant professor between 2000-2006 and received his Associate Professor title in 2007 and his received Professor title in 2017. He is currently continuing his research work at the Department of Pharmaceutical Technology, University of Health Sciences, Gulhane Campus, Ankara. Dr. SAVASER has served as BA/BE Evaluation Commission member since 2011 and is the writer of 40 scientific articles, 6 book chapters.

Dr. Faiyaz Shakeel received a Master degree (M. Pharm) and a PhD in Pharmaceutics from Jamia Hamdard (Hamdard University, New Delhi, India). At Jamia Hamdard. In 2011, he was awarded Young Scientist Award from the Association of Pharmacy Professionals (APP). In March 2016, he has been promoted to Associate Professor at King Saud University. At King Saud University, He also had very good expertise in solubilization of drug molecules using cosolvency models. His research interest lies in the general area of Pharmaceutics and more recently in the development of nanoemulsions and self-nanoemulsifying formulations for therapeutic applications. He is author of over 180 journal articles and book chapter.

Dr M. Skwarczynski received a Master degree in biotechnology and a PhD in chemistry from Wroclaw University of Technology (Poland). In 2004 he was awarded Japan Society for the Promotion of Science Postdoctoral Fellowship, and a grant to conduct research on paclitaxel.His research interest lies in the general area of medicinal chemistry and more recently in the development of nanomaterials for biomedical applications, vaccine delivery strategies, including design, chemoselective synthesis, conformational studies, and immunological properties of lipopeptide and polymer assembled multivalent vaccine candidates. He is author of over 70 journal articles and book chapters.

Dr.Wei Cai received his Ph.D degree from Beijing University of Chinese Medicine in 2015. He is currently an associate professor at school of pharmaceutical science, Hunan University of Medicine. During 2017-2018, he was a visiting scholar at Yale University under the supervision of Prof.Yung-Chi Cheng. He is especially interested in metabolism and pharmacokinetics of traditional Chinese medicine. He has published more than 30 peer-reviewed papers.

Dr. Sagnik Chatterjee, currently working as senior research investigator in BBRC, Bangalore. His group is working on impact of transporters in disposition, toxicity and efficacy of molecules, in normal and in disease conditions. He did his PhD from KU Leuven, Belgium in exploring drug-induced cholestasis (2010-2014). He developed and validated a sandwich- cultured hepatocyte-based system, with externally added bile acids, that is widely accepted and recommended by International Transporter Consortium. Before PhD he worked with AstraZeneca India, in their drug metabolism group (2007-2009). He did his M. S (Pharm) from NIPER, Mohali, India in natural products chemistry (2005-2007). He has published in 9 peer-reviewed articles with present citations tally of 290.

Dr. Hui Ding is the associate Professor of Center for Informational Biology at University of Electronic Science and Technology of China. She received her Ph.D. from Inner Mongolia University, P.R. China in 2009. Her research is in the areas of computational system biology. She has published over 60 peer-reviewed papers in SCI-indexed journals. Her publications have been cited over 3,406 times with H-index of 31 in Google Scholar (update in 2019.8).

Dr. Ianiro received his medical degree in 2009 summa cum laude at the Catholic University of Rome.He trained in gastroenterology at the same University. He is currently gastroenterologist at the Digestive Disease Center of the Fondazione A. Gemelli IRCCS, Università Cattolica del Sacro Cuore in Rome, Italy. He has since gone on to establish himself as a key clinical and translational investigator focusing mainly in the field of intestinal microbiota with 99 peer reviewed publications including some of the best referral journal in Gastroenterology and Internal Medicine, including NEJM, Circulation, Annals of Internal Medicine, Gut, Nature Reviews Gastroenterology and Hepatology, Pharmacology &Therapeutics, Clinical Gastroenterology & Hepatology, Alimentary Pharmacology & Therapeutics, etc.). He was the secretary of two international consensus conferences on fecal microbiota transplantation. He was in the Young Talent Group, and now is in the Research Committee, of the UEG (United European Gastroenterology). Dr. Ianiro has received several research grants in support of his innovative research (the most recent from the Italian Ministry of Health as PI for a project entitled "Targeting gut microbiota to improve efficacy of immune checkpoint inhibitors in patients withadvanced renal cell carcinoma").

Dr. Mohammad Amjad Kamal is a Distinguished Adjunct Professor at the King Fahd Medical Research Center (KFMRC), King Abdulaziz University, Saudi Arabia. He is leading a highly productive global collaborative research team based from Novel Global Community Educational Foundation (NGCEF), Australia. Dr. Kamal's biochemical research in the field of Alzheimer’s disease, Type 2 diabetes and leukemia has culminated in more than 380 publications in internationally respected journals.Dr. Kamal was awarded a prestigious U2000 Postdoctoral Fellowship in 2000 by the University of Sydney. This three years highly competitive award funded his research on the "Inhibition of amido phosphoribosyltransferase by new antifolates". Amongst numerous projects, Dr. Kamal also collaborated on the molecular biological research project “Linkage of Alzheimer’s disease and Type 2 diabetes” at the University of Technology, Sydney. Moreover, he is serving as an EiC/regional/editorial member/guest editor of several reputed scientific journals on honorable basis.

Dr. Supratik Kar is a research associate at Jackson State University, Mississippi, USA. He has completed his B. Pharm. (2008) and M. Pharm. (2010) degree from Jadavpur University (Kolkata, India) securing first position in both degrees and earned his PhD (2015) from the Jadavpur University (Kolkata, India). Former visiting researcher at the University of Gdańsk (Poland). Has experience in molecular modeling studies for ten years. He has published 50 research and review articles, 9 book chapters till date with h-index 20. He has also coauthored 2 QSAR related books in Academic press and Springer. Reviewer of more than 15 reputed journals. ORCID: orcid.org/0000-0002-9411-2091.

Kei Kunimasa, (born December 25, 1981, Hyogo, Japan), studied medicine at Osaka University, graduating with an M.D. in 2006. He later also received a Ph.D. (2016) in medical science from Kobe University. While a graduate student, he researched cell competition using Drosophila melanogaster and found Sas (stranded at second) controls cell competition between normal cell and neighboring cancer cell (Nature. 2017), and he also researched cancer metabolism under Tatsuya Nagano (Cancer Science. 2018). From 2017, he worked at Osaka International Cancer Institute as senior stuff and researched clinical cancer genomics using next generation sequencing with human samples. He won the fund from Japan Society for the Promotion of Science (JSJP)(2019) and Takeda science foundation(2019).

Dr. Marcello Maida attended the medical school at University of Palermo, where he graduated. He is a consultant gastroenterologist at S.Elia- Raimondi Hospital in Caltanissetta, Italy, member of the governing council of the Young Italian Gastroenterologists Association (AGGEI) and Director of the Multimedia Educational Platform of Italian Medical Schools of Gastroenterology (Gastrolearning). He is author of several scientific papers indexed on PubMed and published on impact factor journals. Dr. Maida’s research interests include several areas of liver diseases, including hepatocellular carcinoma, viral hepatitis, autoimmune liver diseases, cirrhosis and non-invasive evaluation of chronic liver diseases.

Dr. Nagano obtained a Ph.D. from the Kobe University Graduate School of Medicine (Kobe, Japan). Dr. Nagano also received M.D. from the Kobe University Graduate School of Medicine and has a 17 years’ experience as physician in general hospital. Currently Dr. Nagano is an Assistant Professor in the Division of Respiratory Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine. His present research field is clinical pharmacology in cancer pharmacotherapy. He has published more than 40 scientific publications and has 1 patent. Dr. Fujita is currently the Executive Guest Editor of this journal (Current Drug Metabolism).

Dr. Nakov is a consultant gastroenterologist at Tsaritsa Yoanna University Hospital, Sofia. He obtained a doctorate (PhD) in Gastroenterology from the Medical University of Sofia. Dr. Nakov is a member of Young Talents Group and Education Committee at United European Gastroenterology (UEG), a course director of UEG Summer School and a president at Association for young hepatogastroenterologists in Bulgaria.

Dr. Pereira is Graduated in Biological Sciences from the Regional University of Cariri (URCA). PhD in Biotechnology from the Federal University of Pernambuco (UFPE-RENORBIO. Has experience in Microbiology, Toxicology of Natural and Synthetic Products and Biosafety, acting on the following subjects: antibacterial activity, inflammation, toxicity and cancer. He is a reviewer for several international journals.

Dr. Lv-Hui Sun is a Full Professor in the Department of Animal Nutrition and Feed Science at Huazhong Agricultural University. Before taking the faculty position here, he worked as a Visiting Ph.D. student at the department of Animal Science at Cornell University from 2010 to 2012. He received a Ph.D. degree in Comparative Nutrition between Human and Animal from Sichuan Agricultural University in 2013 and B.S. degree in Animal Science from Wuhan Polytechnic University in 2007. His current research aims at understanding the molecular mechanisms of mycotoxins hepatotoxicity and immunotoxicity and dietary strategies to counteract the toxic effects of mycotoxins.

Dr. S.R. Tintino completed his graduation in Biological Sciences from the Regional University of Cairri. He further obtained a PhD in Biotechnology from the Federal University of Pernambuco. He is currently serving a Substitute Professor at the Regional University of Cairri-URCA and he is also a Coordinator of the Universal CNP project. He is a member of the research group of the Laboratory of Microbiology and Molecular Biology. He is experienced in the area of Microbiology, with emphasis on antimicrobial activity of natural products and isolated substances and in the Genetics of Microorganisms with emphasis on mechanisms of inhibition of bacterial efflux pumps. He also has an experience in studies of antioxidant activity and cytotoxic activity of natural products and isolated substances. He is a reviewer for several international journals.

Dr. Nuno Vale is an Invited Professor of Pharmacology (Pharmacokinetic and Drug Metabolism) at the Faculty of Pharmacy of the University of Porto. His research interest lies at the intersection between Biomedical Sciences and Pharmacology, namely on the development of new conjugates with peptides and nanoparticles for drug delivery in cancer and central nervous system. His main research focus is also on the Pharmacokinetic and Drug Metabolism of approved drugs for drug repurposing, and in PBPK Modeling and Drug-Drug Interactions.

Dr. Yi Wang is a Professor in College of Pharmaceutical Sciences at Zhejiang University. He received his Ph.D. in Pharmaceutical Analysis from Zhejiang University in 2007. His laboratory is devoted to the modernization of traditional Chinese medicine (TCM). He is especially interested in screening and identifying bioactive compounds from TCM as well as revealing their ADME properties and mechanism of action. Dr. Wang’s lab established a set of bioassays including cellular, zebrafish, and animal models. He has published more than 50 peer-reviewed papers, book and chapters.

Professor/Dr. Jiayu Zhang received his Ph.D degree PhD of pharmacognosy (Chemistry of Chinese Materia Medica) from Peking University. He is currently a professor at BIN ZHOU Medical University. During 2011-2019, he worked in Beijing University of Chinese Medicine, which is a famous University of traditional Chinese medicine in China. He is especially interested in metabolism and pharmacokinetics of traditional Chinese medicine. He has published more than 70 peer-reviewed papers.

Dr. Shammas is employed as a Lead Scientist in the field of Translational Cancer Research at Harvard (Dana Farber) Cancer Institute, Boston, USA. His research focuses on understanding mechanisms underlying genomic instability and their translational significance in cancer, including Barrett’s esophageal adenocarcinoma. He has developed novel tools/assay systems to study genomic evolution in cancer and has identified key targets and novel drugs to inhibit/reduce genomic evolution, whether intrinsic to cancer cell or that induced/increased by chemotherapeutic agents. These drugs have potential to inhibit tumor growth, overcome/minimize harmful genomic impact of chemotherapy and inhibit/delay progression of cancer to advanced and more aggressive stages. He is a co-author over 60 scientific publications including book chapters and has trained a number of students (undergraduate, graduate), postdoctoral fellows and clinical fellows. He has served and/or serving as Principal Investigator, Co-Principal Investigator and/or Co-investigator on several research grants from the NIH (USA), including R01 grant or even larger grants, including Program Project and Specialized Programs of Research Excellence grants from NIH. He is serving or has served as a Founding Editor, Editor, Lead Guest Editor and/or Guest Associate Editor for several scientific journals, a Grant Reviewer, and as an External Examiner for PhD students for Universities abroad.

Professor Harikesh Bahadur Singh has served as Professor & Head, Department of Mycology and Plant Pathology at Institute of Agricultural Sciences, Banaras Hindu University. His major research focus is on bioinnoculats, biological control of plant pathogens and nano-biotechnology. Professor Singh has been decorated with several prestigious National awards and honours for his scientific contributions in the field of organic farming and translational agriculture, notable being CSIR Technology Prize for Biological Sciences by Hon’ble Prime Minister of India, M.S. Swaminathan award by Society for Plant Research, Vigyan Bharti Award, Prof. V.P. Bhide Memorial Award, Society for Plant Research, and many more. He has been able to add more than 300 publications and 20 U.S. patents to his credit which have been successfully transferred for commercialization.

Dr. Ram Gupta joined Pittsburg State University as an Assistant Professor in 2013. Before joining to Pittsburg State University, he worked as an Assistant Research Professor at Missouri State University, Springfield, MO then as a Senior Research Scientist at North Carolina A&T State University, Greensboro, NC. Dr. Gupta’s research focus on green energy production and storage using conducting polymers and composites, nanomaterials, optoelectronics and photovoltaics devices, organic-inorganic hetero-junctions for sensors, nanomagnetism, bio-based polymers, bio-compatible nanofibers for tissue regeneration, scaffold and antibacterial applications, bio-degradable metallic implants. Dr. Gupta has published more than 150 articles in peer-reviewed journals and presented/attended more than 100 national/international conferences. He is a member of editorial board and reviewer for various leading science journals. Dr. Gupta has received several internal and external (NSF, DoE, KINBRE, USA) funding to promote research and educational activities.

Dr. Jianyong Xu obtained his Ph.D. degree (in 2016) in the field of Medicine from The University of Hong Kong, Hong Kong. Dr. Xu is currently working as Assistant Professor, in the School of Medicine, at Shenzhen University, Shenzhen, China. His research interests mainly lie in the subject areas/fields of stem cell biology, genome editing, gene therapy and their therapeutic applications. Dr. Xu, as an author/co-author, has published more than 20 manuscripts in various journals of international repute, and his documents have received over 2,290 citations.

Dr.Gaurisankar Sa obtained his Ph.D. degree (in 1990) in Biochemistry from University of Calcutta, Kolkata, India. Dr. Sa is currently affiliated with Bose Institute, Kolkata, India, as Senior Professor in the Division of Molecular Medicine. His research interests mainly lie in the subject areas/fields of Tumor Immunology and Cancer Biology. Dr. Sa, as an author/co-author, has published more than 50 articles in various journals of international repute, having over 1,325 total citations.

Dr. Chunxiang “Kevin” Zhang, MD, PhD, FACC, is presently serving as a tenured Professor at the University of Alabama at Birmingham, School of Medicine. He has over 20 years of experience and expertise in the areas of basic, translational and clinical cardiovascular research. Dr. Zhang had worked as the Vice Chairman for Research at New Jersey Medical School. From 2010-2016, He had worked at Rush University as the Chairman of the Pharmacology Department. Dr. Zhang’s research team is a pioneering group to explore the roles of Non-coding RNAs in HIV and anti-HIV-drug-induced aging; cardiovascular biology and cardiovascular diseases. He has obtained over n$20 million research grants from NIH, AHA and ADA. Dr. Zhang’s current research programs are focused on non-coding in atherosclerosis & restenosis, myocardial infarction, cardiac hypertrophy, cardiovascular aging and diabetic cardiovascular complications.

Dr. Hong Lin received his PhD in Computer Science and was a postdoctoral research associate at Purdue University, an assistant research officer at the National Research Council, Canada, and a software engineer at Nokia, Inc. Dr. Lin is currently a professor in University of Houston-Downtown (UHD) Houston, TX. His research interests include data analytics, human-centered computing, and parallel/distributed computing. He is a senior member of the ACM.

Dr. Galileo Escobedo’s main research interest is focused on the immunometabolic mechanisms involved in obesity and insulin resistance, especially in the bionomial mother- infant. Dr. Escobedo currently supervises several students of B.Sc., M.Sc., and Ph.D. programs as well as postdoctoral fellows, and has been awarded with research grants from the Mexican Council of Science and Technology (CONACYT) and the Marie Curie International Research Program of the European Community. Dr. Escobedo has published more than 60 original research papers and reviews in JCR international journals and written several book chapters related to the inflammatory response in obesity and type 2 diabetes.

Dr. Yan Kong is an Associate Professor in the Department of Biochemistry and Molecular Biology, Medical School of Southeast University, Nanjing, China. Dr. Kong received his Ph.D. degree in Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences in 2010. His research mainly focuses on neurodevelopmental and neurodegenerative disorders, epigenetics and noncoding RNAs.

Chiara Sassoli graduated in Biological Sciences with summa cum laude at the University of Florence, Italy in 1999. In 2000 -2001 she was Guest Researcher at Blanchette Rockefeller Neurosciences Institute, Johns Hopkins University, Gaithersburg-MD-USA. In 2005 she obtained the Ph.D. degree in Human Morphology and Morphogenesis from the University of Florence, Italy. From 2005 to 2009 she was Postdoctoral Research Fellow and from 2009 she is Assistant Professor of Human Anatomy at the Department of Experimental and Clinical Medicine, Section of Anatomy and Histology, University of Florence, Italy. Research interests: cellular and molecular mechanisms involved in tissue repair/regeneration especially at skeletal and cardiac muscle and bone tissue;effects of different factors (sphingolipids, relaxin, platelet-rich plasma), mesenchymal stromal/stem cells and photobiomodulation/Low Level Laser Therapy on tissue healing

Somayeh Shahrokhi received her PhD in immunology from Tarbiat Modares University, Iran at 2010. She joined Lorestan University of Medical Sciences and she is currently an Associate professor of Immunology. She has two major research interest; Immuno-oncology and stem cell research. The cancer research studies started by compounds screening to test for future clinical applications. This was followed by studying breast cancer in animal and human studies. Her main accomplishments include; nationally recognized as an outstanding life science researcher, published more than 20 peer review articles, a book chapter, a patent and guest editor of special issue.

Prof. Zhang joined in Tianjin Medical University Eye Hospital after she received her PhD in 2004. She did one year of postdoctoral work from 2005 to 2006 at Rothschild Hospital and University Paris 12 in Paris. She has been the deputy director of Tianjin Medical University Eye Institute and the director of Ocular Inflammation and Immunology Department of Tianjin Medical University Eye Hospital since 2012. She specializes in the diagnosis and therapy of ocular immunological diseases including uveitis and scleritis. Her research interests are mainly in developing new therapy for refractory ocular immunological diseases and stem cell therapy for ocular disease.

Dr. Neeraj Mishra is working as a Professor in Amity Institute of Pharmacy, Gwalior from July, 2019. He worked as a professor in pharmaceutics at ISF College of Pharmacy, Moga from June 2012 to May 2019. He has completed his B. Pharm (2000), M. Pharm (2003) and Ph.D. (2011) in Pharmaceutical Sciences from Department of Pharmaceutical Sciences, Dr. H.S. Gour Central University, Sagar (M.P.). He was qualified in National Level Test GATE conducted by IIT, Kanpur in 2001. He is having more than Sixteen years teaching/ research experience at post graduate. He is working as a brand ambassador of Bentham Science, USA. He has supervised more than 30 M Pharm students. He is having 48 International and 24 National Publication typically in recent concept of novel drug delivery system, particularly in vaccine delivery and drug targeting. He has also written 5 books chapter in national and International publisher (Nova Science Publishers).

Dr. Fotios Sampsonas is currently working as a Locum Consultant of Respiratory Medicine in Patras University Hospital (with clinical and academic commitments). Presently, he is awarded a Scholarship from the Hellenic Respiratory Society that further supports the clinical service and his academic commitments. Previously, he worked as a Clinical Lecturer of Respiratory Medicine in Galway University Hospitals. He is actively involved in teaching medical students respiratory and general internal medicine. Dr. Sampsonas has around 34 Medline Publications to his credit.

Suowen Xu, Ph.D., is a natural product pharmacologist. Dr. Xu received his Ph.D. did postdoc studies in biochemistry at NHLBI/NIH, followed by a second postdoc in vascular biology at University of Rochester. Currently, Dr. Xu is Research Assistant Professor of Medicine at University of Rochester. He is a principal investigator interested in identifying novel therapeutic targets and molecular interventions of cardiovascular diseases. He was also an adjunct faculty member (Associate Professor) in the School of Pharmacy, The University of Queensland. He is an editorial board member of 4 journals and serves as reviewers for over 50 journals.

Dr. Serkan Yilmaz is serving as Professor, in Ankara University Faculty of Health Sciences.He did his Ph.D in Genetics from Gazi University, Turkey. He is an official member of a number of international societies. He received awards from The Scientific and Technological Research Council of Turkey, Gazi University and Ankara University. His research interests are genetics, toxicology, genetic diseases, pharmacology, toxicology and Molecular biology.

The research carried out by Dr. Alfonso Alfaro-Rodríguez has focused in the study of the chemistry of the brain. His studies are centered in the search for neuronal damage mechanisms caused by neurodegenerative diseases like Parkinson's, brain injuries, and currently nociception. He has also dabbled in the study of several antiepileptic and antidepressant drugs over the central nervous system. The role of monoamines like serotonin and acetylcholine along with several catecholamines at neuronal and molecular level in the development of neurodegenerative diseases has been a central topic of his research. The research over the mechanisms of brain damage by means of different neurotoxic pathways unchained by neurodegenerative diseases has led him to successfully explore the role of neuroprotective drugs in a myriad of animal models. With his research he has allowed the assessment of neuronal damage and the disabilities caused by these diseases. At present he has centered in the development of novel research protocols over the mechanisms of pain and the elaboration of diagnostic strategies for the timely diagnostic of it; by means of the employment of new drugs that could improve quality of life of patients suffering of chronic pain.

Seyed Mohammad Nabavi is a biotechnologist and senior scientist of Applied Biotechnology Research Center, Baqiyatallah University of Medical Science and a member of Iran's National Elites Foundation. His research focuses on the molecular pharmacology of natural products. He is author/co-author of 250 publications in international journals, 51 communications at national and international congress, and six chapters in book series. Seyed Mohammad Nabavi has been selected as a group of scientists recognized as Highly Cited Researchers by Clarivate Analytics, 2018.

Dr. Jayesh J. Ahire is a Research Scientist in the Center for Research and Development, Unique Biotech Limited, Hyderabad, India. He received Ph.D. Microbiology (2013) in the field of probiotics and its biogenic metabolites from North Maharashtra University, Jalgaon, India. Later, from March 2013 to April 2018, Dr. Ahire worked as a postdoctoral researcher in the Department of Microbiology, Stellenbosch University, Stellenbosch, South Africa and explored research on Nanotechnology and Microbiology. He has around 5 years of research experience in field of Bio-nanotechnology. Dr. Ahire published several research articles in peer-reviewed journals and serving as a reviewer for peer-reviewed journals. To date, Dr. Ahire reviewed 44 articles for Current Nanoscience, 10 for Micro and Nanosystems and 1 for Recent Patents on Biotechnology. Dr. Ahire’s professional interests are in the area of Nano-biotechnology.

Dr. Patrizia Bocchetta received Chemical Engineering Degree from University of Palermo in the year 1999 and the PhD in 2003 from Politecnico of Milano. In 2012, she became an Assistant Professor of Applied Electrochemistry at the Engineering Faculty of the University of Salento. Her main research interests focuses on (i) electrocatalytic materials for oxygen reduction reaction; (ii) novel proton exchange membranes for H 2 /O 2 fuel cells; (iii) porous anodic alumina; (iv) in-situ spectroelectrochemistry; (v) synthesis and characterization of nanostructured materials; (vi) conductive and bio-compatible polymers; (vii) zn-air batteries; (viii) chitosan-based materials for energy conversion and sensors.

Prof. Yu Duan obtained his Ph.D. degree (in 2001) in microelectronics and solid-state electronics from Jilin University, China. Prof. Duan is currently employed as Professor, in the College of Electronic Science & Engineering, at Jilin University. His research interests mainly lie in the subject areas / fields of organic semiconductors and optoelectronics. Other research areas include printing nanoparticle, AgNW, and graphene. Prof. Duan, as an author/co-author, has published more than 100 articles in various journals of international repute, and his documents have received total citations of over 1,160.

Dr. Bodgan Alexandru Sava (M) is a senior researcher with vast experience in new methods; laser glass, Ms, PLD , plasma chemical and microwave, sol-gel, coprecipitation; nano structured materials; materials for optoelectronics, nonlinear optics, magneto-optics and electronics; high purity materials; optical glasses and optical glass filters; glass-ceramics; quartz glasses and doped quartz glasses. He was involved in 29 international and national research projects as coordinator or responsible, from whom 8 in last 10 years; 51 articles published in ISI indexed Journals, 6 articles published in other databases Journals, 33 contributions in ISBN volumes, 4 patents, 13 international awards.

Dr. Liqiang Wang is an associate professor in Shanghai Jiao Tong University. He got his BS and MS degrees both from Xi’an University of Architecture and Technology in materials science in 2006. Then he became a graduate student in department of materials science and engineering in Shanghai JiaoTong University, where he got his Ph.D. in 2009. His research focus is towards preparing, processing and analyzing of biomedical titanium alloys and titanium matrix composites. He has been a member of many national and international committees and associations. To-date, he has contributed more than 70 journal, book and conference publications, including 10 plenary, keynote and invited talks, 5 book chapters.

Hongjing Wu is an associate professor of Materials Physics and Chemistry at the School of Science of Northwestern Polytechnical University (NPU), Xi’an, China. He received his B.S. and M.S. degrees at Applied Chemistry and Chemistry of China University of Geosciences (Wuhan) in 2007 and 2010. He earned his Ph.D. degree at Materials Physics and Chemistry, NPU, in 2014. During 2012 and 2013, he worked as a visiting scholar at Institute of Nanostructured Materials, Italian National Research Council (CNR-ISMN), supported by China Scholarship Council. In 2014, he was appointed as an associate professor at School of Science of NPU. His current research activities center on design, characterization and application of nano-oxide based materials with the focus on environmental catalysis, Li-ion battery energy storage, and electromagnetic wave absorbing properties of nano-oxide based materials. He authored and co-authored 85 scientific papers published on ISI journals in the field of materials science and energy. Publications were cited by Google scholar for more than 2978 times, H-index: 32.

Dr. Xiuhua Zhao is a Research Professor at the Ministry Education Key Laboratory of Forest Plant Ecology, Northeast Forestry University. He did his Ph.D. in Botany from Northeast Forestry University, Harbin city, Heilongjiang in the year 2009. His Research interests are (a) Extraction, separation of and purification of native compounds (b) Nanomedicine (c) Design and evaluation of drug delivery (d) bioavailability or bioaccessibility enhancement of poorly soluble drugs by nanotechnology (e) Biomaterials.

Dr. Hari Shanker Sharma obtained his PhD in 1982 from Banaras Hindu University and Dr Med Sci in 1999 from Uppsala University and engaged in Neuroscience research over 40 years. He is currently the Director of Research International Experimental CNS Injury & Repair (IECNSIR) based at Uppsala University. He authored more than 250 original research papers and Edited several Books in Progress in Brain Research Series and International Review of Neurobiology series. His current research includes Nano delivery of drugs to treat CNS injury and enhance neurorepair.

Dr. Banerjee received his PhD degree from Visva-Bharati University, Santiniketan West Bengal, India. He has nearly eight years of experience in the field of research related to green and sustainable development. He is presently working as an Assistant Professor of Chemistry at the Department of Chemistry, Indus International University, Batho Una Himachal Pradesh India. Dr. Banerjee has published more than 50 research articles all in the internationally renowned journals and has authored two book chapters also.

Dr. Javier Eduardo García Castañeda PhD is presently serving as an Associate professor in Pharmacy Department, Sciences Faculty of Universidad Nacional de Colombia (2009- ). He was also a visiting professor in the Chemistry Department - CINVESTAV México (2007-2008). He also worked as a researcher in the Immunology Institute (Hospital San Juan de Dios- FIDIC) (1994-2006). His research interest include Identification of cell binding sequences of proteins involved in infection process of HCV, M. tuberculosis, HPV, etc. Peptide Characterization using RMN, MALDI- TOF MS, LC-MS, Circular Dichroism, etc. Production of polyclonal antibodies in animal models (mouse, Goat and rabbit).

Prof. Yong Chen worked in School of Environmental Science and Engineering, Huazhong University of Science and Technology, Wuhan, China since 2009, when he obtained his Ph.D. degree at State Key Laboratory of Environmental Aquatic Chemistry, Research Center for Eco-Environmental Sciences, Chinese Academy of Sciences. In 2006, he obtained his M.S. degree at School of Resources and Environmental Science, Wuhan University. In 2000, he obtained his B.S. degree at Chemical department, Hubei Normal University. He is a Visiting professor, Department of Chemistry & Biochemistry, University of Massachusetts Dartmouth, University of Waterloo and Western University in 2012 and 2016, respectively. His primary research interests include Advanced oxidation processes for wastewater treatment; Groundwater remediation; Environmental photochemistry, and Occurrence and fate of emerging pollutants.

Dr. Puyou Jia obtained a Ph.D in 2016 at the Beijing Forestry University, China. Then, he joined the Institute of Chemical Industry of Forestry Products, Chinese Academy of Forestry (CAF). He is an associate professor and focus on synthesis of bio-based & biomass-based monomers and polymers. He has spearheaded a few interdisciplinary initiatives that combine expertise in the fields of polymer synthesis and materials chemistry. He is interested in the atom-efficient, eco friendly, highly efficient chemical transformations of a variety of biomass into sustainable intermediates, polymer auxiliaries, bioplastics, elastomers and advanced bio-based materials. He has published more than 100 academic papers.

Dr. Gyorgy Kelevich completed his graduation as a Chemical Engineer and his PhD is in Chemical Sciences. He has been serving as a Professor of Chemistry since 1995 and the Head of the Department of Organic Chemistry and Technology, Budapest University of Technology since 1999. He is engaged with P-heterocyclic and environmentally-friendly chemistry comprising MW chemistry, phase transfer catalysis and the development of new catalysts. He is the author and Co-author of 460 papers and also hold the editorial position in different Scientific Journals. He is a member of the Editorial Board of Heteroatom Chem. and Phosphorus Sulfur Silicon.

Huizhen Liu, professor at Institute of Chemistry, Chinese Academy of Sciences (CAS). She received B.S. degree in Applied Chemistry at Qilu University of Technology in 2005, M.S. degree in Organic Chemistry at Changchun University of Technology in 2008, Ph.D. degree in Physical Chemistry at Institute of Chemistry, CAS in 2011, and did postdoctoral research at the École Polytechnique Fédérale de Lausanne, EPFL, Switzerland from 2012 to 2014. She has been a professor at the Institute since 2015. Her research interests include the transformation of CO2 and biomass into valuable chemicals and fuels. She has published more than 50 papers in peer-reviewed scientific journals, such as Science, Nat. Commun., Angew. Chem. Int. Ed. , and the papers have been cited more than 1200 times. She has also published 3 patents.

Krishnaiah Maddeboina received her B.S. and M.S. degree in chemistry from the Sri Venkateswara University, Tirupati, AP, India in 2000 and 2002 respectively. He completed his Ph. D. in 2011 at Indian Institute of Chemical Technology, Organic Chemistry Division-I, Hyderabad. After Ph.D., I have completed post-doctoral training at Ewha Woman's University, Seoul, where I have designed and synthesized a series of trisubstituted imidazoles, thiazoles, and pyrazoles as a potent and selective TGF- β type I receptor kinase inhibitors. The results of these studies were reported in internationally reputed journals. I have also completed several R&D projects containing amino acids, azo-derivatives, and OLED materials. One of our compound EW-7197 (TEW-7197) has been approved from the US FDA for phase II clinical trials with emphasis on subjects with melanoma, breast cancer, hepatocellular carcinoma, and prostate cancer (NCT02160106). Currently, focusing on the dual kinase and epigenetic inhibitor for treating cancer at the Pediatrics Computational Chemistry, University of Nebraska Medical Center, Omaha, USA.

Teresa M. V. D. Pinho e Melo studied Chemistry at the University of Coimbra, where she obtained the PhD in Organic Chemistry in 1995. She was Research Fellow at the University of Liverpool (1992-1993). She received her Habilitation in Organic Chemistry in 2003. She is currently Director of the Department of Chemistry, Associate Professor with Habilitation and Head of the Organic Chemistry Research Group at the University of Coimbra. She is also President of the Division of Organic Chemistry of the Portuguese Chemical Society. She has published more than 115 peer-reviewed scientific papers in international journals. Her research interests are in the area of synthetic and mechanistic heterocyclic organic chemistry. She is particularly concerned with the development of synthetic routes to new bioactive molecules.

Mihai V. Putz is currently Full Professor of structural physical chemistry and Director of Doctoral School of Chemistry at West University of Timisoara, Romania. He is vividly promoting a new theory of chemical bonding (by the newly investigated bosonic quasi-particle coined by him as the BONDON) towards a unitary quantum approach targeting the bio-, pharmaco- and econo-ecological analytical description. With many international and national fellowships, awards and memberships (American Chemical Society, DAAD, etc.), he is an active international scholar in multidisciplinary chemistry, by authorship and editing books, monographs, special issues and, more recently international conferences.

Toshifumi Dohi (TD), a Professor at Ritsumeikan University, received his MS degree in 2002 (Prof. S. Murai) from the Graduate School of Engineering of Osaka University, Japan, and PhD in 2005 (Prof. Y. Kita) from the Graduate School of Pharmaceutical Sciences of Osaka University, where he studied new reactivities of transition metal catalysts and synthetic chemistry using hypervalent iodine reagents. After finishing PhD work, he subsequently became Assistant Professor at Osaka University, and was promoted to Associate Professor (PI) in 2014 at Ritsumeikan University. His current research interest is focused on reagent/catalyst design and asymmetric oxidation in hypervalent iodine chemistry. T.D. received the IUPAC-ICOS 15 Poster Award for most excellent presentation, the PSJ Award for Young Scientists (2009), Banyu Chemist Award (2013), Thieme Chemistry Journal Award (2014), and GSC Encouragement Award (2015) on his researches. For more details, see: http://www.ritsumei.ac.jp/pharmacy/dohi/ at this homepage.

Dr. Gjumrakch Aliev received his MD in 1982, from the Baku Medical University (former USSR) with cum laude. Then he accomplished his PhD in Cardiovascular Diseases from the prestigious Russian Academy of the Medical Sciences, Moscow, Russia in 1989 with cum laude. He received postdoctoral training with Professor G. Burnstock in the University College of the London. He authored and coauthored more than 500 publications in the fields of neurodegenerative diseases research (Alzheimer disease), as well as cardio- and cerebrovascular disease, cancer, and electron microscopy. Dr. Aliev’s accomplishments in the area of biochemistry and cellular biology have tremendous implications for drug design towards CNS Neurological Disorders, AD, cancer, and cerebrovascular and neurodegeneration related pathologies. He is world-renowned expert in electron microscopy. He is currently the Editor in Chiefs for “Central Nervous System Agents in Medicinal Chemistry”, “Applied Cell Biology”, “World Journal of Neuroscience”, “Open Journal of Psychiatry”, “Journal of Aging Science”, “Cardiovascular & Hematological Agents in Medicinal Chemistry”, “Immunology, Endocrine and Metabolic Agent in Medicinal Chemistry” as well as which by itself shows the voluminous and outstanding work he has accomplished in the area of cellular and molecular biology as well as aged associated clinical sciences.

Prof. Sanjula Baboota is presently working at the Department of Pharmaceutics, School of Pharmaceutical Education and Research (SPER), Jamia Hamdard. She has a total experience of about 23 years in teaching and research. She has a list of over 200 publications in high impact factor refereed journals. She has guided several students both at the at the postgraduate and doctorate level. She has more than 7300 citations and has an h-index of 43 and i10 index of 120 (Source: Google Scholar).

Prof. Dr. Marcio F. Chedid obtained his MD degree by the Medical School of the Federal University of Rio Grande do Sul (UFRGS) in Porto Alegre, Brazil in 2004. Prof. Chedid concluded a five-year General Surgery and Surgical Oncology Residency at Hospital de Clínicas de Porto Alegre (HCPA-UFRGS) in Porto Alegre, Brazil in 2010. He worked as a Clinical Fellow at the Division of Abdominal Transplantation Surgery of Mayo Clinic in Rochester, Minnesota USA, from 2011 to December 2013. Since May 2014, Prof. CHEDID is an Attending Liver and Pancreas Transplant Surgeon at HCPA-UFRGS. Prof. Chedid obtained a PhD degree in Surgical Sciences at UFRGS in February 2017 and has worked as Postgraduate Professor of Surgery and Master´s Degree Thesis Advisor at the Medical School of UFRGS since September 2017. He has authored/co-authored 47 scientific medical articles, including the one first reporting successful performance of human pancreas transplantation utilizing IGL-1 preservation solution (https://www.ncbi.nlm.nih.gov/pubmed/27163542). Prof. Chedid is one of the associate editors of the World Journal of Gastrointestinal Surgery and also is a member of the editorial board of Annals of Translational Medicine and Lipids in Health and Disease. Prof. Chedid is a reviewer for 31 PubMed Indexed scientific journals. 

Dr. Jiwei Hu is currently a Chair Professor at Guizhou Provincial Key Laboratory for Information Systems of Mountainous Areas and Protection of Ecological Environment as well as at Cultivation Base of Guizhou National Key Laboratory of Mountainous Karst Eco-environment, Guizhou Normal University. He obtained B.S. in chemical engineering from Zhejiang Institute of Technology in 1984, M.S. in organic chemistry from University of Jyväskylä in 1994, Licentiate in environmental chemistry from Stockholm University in 1996, and Ph.D. in applied chemistry from University of Jyväskylä in 1999. He carried out his research at College of Chemistry and Molecular Engineering, Peking University, as a Post-Doctoral Fellow from 2002 to 2005. He received in 2018 the International Association of Advanced Materials (IAAM) medal in Sweden and the Science Technology Cooperation Award of Guizhou Province. He has so far authored and co-authored approximately 180 conference and journal papers and his work has led to 7 patents.

Prof. Dr. Sher Bahadar Khan did his Ph.D from HEJ, Karachi University, Pakistan. After completion of Ph.D, He started his post-doctoral career in Nanochemistry and Nanotechnology and continued to work as a post-doctoral research fellow till February 2010 at Yonsei University, South Korea. In March 2010, He joined Center for Advanced Materials and Nano-engineering, Department of Chemistry, Najran University as an Assistant Professor and continued his work till 31 st August 2011. He joined the Chemistry Department, King Abdulaziz University, Jeddah, Saudi Arabia as an Assistant Professor in September 2011. Currently he is full Professor in the Chemistry Department, King Abdulaziz University and is doing research in Nanochemistry and Nanotechnology which comprises catalysis, hydrogen production, drug delivery, solar cell, development of active photo-catalyst and fabrication of perceptive bio-sensor and chemi-sensor using metal oxide nanomaterials and their green environmental nanohybrids. He is the author of 300 research articles, twelve books, and six patents with more than 850 impact factor, 5650 citations and 41 h-index.

Weiwei Xue received his B.S. (2009) and Ph.D. (2014) degree in Department of Chemistry at Lanzhou University. He worked as a visiting scholar of the Department of Biochemistry at University of Washington School of Medicine (2018-2019). He is now an associate professor of the School of Pharmaceutical Sciences at Chongqing University. His research interests focus on employing principles of physics and chemistry with modern computational techniques to understand the molecular mechanism underlying chemical and biological processes (protein−ligand/protein interactions and protein folding), and to design novel therapeutic candidates. Dr. Xue has published more than 50 peer-reviewed research papers with over 1000 citations and h-index of 23.

Wenzheng Bao received his Ph.D in computer science from Tongji University in 2018. He received the master degree in computer science from the University of Jinan in 2015. He currently works for school of information and electrical engineering, Xuzhou University of Technology, Xuzhou, China. His research interests include bioinformatics, machine learning, computational biology and proteomics.

Prof. Kwang-sun Kim graduated from Chonbuk National University, Korea, with a B.S. degree in Chemistry (1998). In 2000, he received an M.S. degree of nucleic acid biochemistry at the Department of Chemistry, Seoul National University, Korea. From 2000 to 2004 Prof. Kim completed a Ph.D. program at the Department of Chemistry in Korea Advanced Institute of Science and Technology (KAIST). From 2006 to 2010, Prof. Kim joined the School of Medicine at Stanford University as a Post-doctoral Fellow under the guidance of Prof. Stanley Cohen, a pioneer of genetic engineering. After research training at Stanford, he joined as a senior researcher at Korea Research Institute of Bioscience and Biotechnology (KRIBB) (2010). From 2010 to 2015, he was assigned as an adjunct Assistant and Associate Professor at the University of Science and Technology (UST), Korea. In 2015, Prof. Kim finally moved to the Department of Chemistry, Pusan National University and joined as an Assistant Professor with tenure. His early researches are aimed at the biogenesis of bacterial small noncoding RNAs and the elucidation of mechanism of action of specific ribonucleases, related proteins, small non-coding RNAs, and to identify cellular functions that regulate the actions of above molecules. His current interest focuses on the developing new concept materials and vaccines and the identification of antibiotic resistance mechanism to combat diseases caused by bacterial pathogens. He is also working as an editorial board member of World Journal of Biological Chemistry from 2018 and an Ambassador at Bentham Science Publisher from 2019.

Mauro Salvi received his B.S. degree in Biology (1998) and Ph.D. degree in Biochemistry and Biophysics (2002) from the University of Padova, Italy. Mauro Salvi joined the faculty at the University of Padova in 1996 as Assistant Professor and was promoted to Associate Professor in 2015. His current research projects are all addressed to work out phosphorylation-based regulatory mechanisms in different signal transduction pathways studying the kinase (function, regulation, partners etc.) and the target protein substrate/s (physiological role of phosphorylation) with a combination of in silico, in vitro and in cell experimental approaches.

Dr. Timothy Veenstra received his PhD in biochemistry from the University of Windsor in Canada followed by completion of a post-doctoral fellowship at the Mayo Clinic in Rochester, Minnesota. It was at the Mayo Clinic that he recognized the value of applying mass spectrometry (MS) to biomedical research. He has spent most of his career in research, utilizing MS in the fields of oncology and neurology to identify biomarkers for disease detection as well as identifying protein interactions key to disease progression. He has co-authored almost 400 peer-reviewed manuscripts and is the author of the book “Proteomic Applications in Cancer Detection and Discovery”.

Dr. En-Qiang Chen has graduated from Sichuan University( Chengdu, China) and served as Associate professor in Center of Infectious Diseases, West China Hospital of Sichuan University. He has published more than 50 full peer reviewed publications, 8 book chapters, 15 presentations at international meetings, 2 peer reviewed funded grants and 1 authorized patent. In recent years, he has focused on the basic and clinical research of stem cells in the treatment of liver diseases.

Isotta Chimenti is Assistant Professor at the Department of Medical Surgical Sciences and Biotechnologies, Faculty of Pharmacy and Medicine, and Junior Fellow of the Superior School for Advanced Studies at “La Sapienza” University of Rome. She is eligible as Associate Professor, according to the Italian National Scientific Qualification program. Her education includes a Master of Science in Medical Biotechnology, and a PhD in Experimental Medicine. She has been a postdoc fellow at Johns Hopkins University, at Cedars Sinai Heart Institute, and at Pasteur Institute – Italy. Her research activity is focused on regenerative medicine, in particular on cardiac cell therapy and cardiac tissue engineering, adult stem cells, and oxidative stress in the cardiovascular system. She is funded as PI by several Italian National grants, and participant in a European Horizon 2020 project. She co-authored over 55 Scopus indexed publications.

Yonggang Lv received the Ph.D. degree in Refrigeration and Cryogenic Engineering with specialty in bioengineering from the Technical Institute of Physics and Chemistry, Chinese Academy of Science, Beijing, in 2005. He served as a postdoctoral research associate/research fellow at the City College of the City University of New York and Memorial Sloan-Kettering Cancer Center. He joined the Bioengineering College at Chongqing University as Full Professor in March 2009 and won the Program for New Century Excellent Talents in University, Ministry of Education of China in 2010. He became a senior visiting scholar in Prof. Shu Chien’s laboratory at University of California, San Diego (UCSD) from July to October 2014. He has published over 100 peer referred journal papers, edited 3 books, and holds 9 China patents. His research interests include mechanobiology and regenerative medicine, stem cell biology, and cancer biology. Dr. Lv is the Vice Chairman of hemorheology committee in Chinese Society of Microcirculation. He is an associate editor of Medical & Biological Engineering & Computing and an editorial member of Biotechnology Letters.

Dr. Ajay Singh Verma obtained his Ph.D. degree (in 2006) in Physics from Dr. Bhimrao Ambedkar University, Agra, India. Dr. Verma is currently working as an Assistant Professor in the Department of Physics at Banasthali Vidyapith (Banasthali University), Vanasthali, India. His research interests mainly lie in the subject areas/fields of Solid State Physics, Thermal Conductivity, Condensed Matter Physics, Material Characterization, Nanomaterials, and Thermal Properties. Dr. Verma, as an author/co-author, has published more than 90 articles in various journals, having over 795 total citations.

Prof Richard (Chunhui) Yang is Lead Director Academic Programs (DAP), Engineering and Industrial Design and the Professor of Mechanical Engineering and Smart Structures in the Western Sydney University (WSU), Australia. Richard received his PhD in Mechanical Engineering in the University of Hong Kong (HKU) in 2002. His fields of research include multi-scale modelling of advanced engineering materials and structures, structural health monitoring (SHM) and smart structures, advanced manufacturing and Industry 4.0, metal forming, and metal surface treatment, etc. He has been awarded 1 ARC DP grant in composites, 2 ARC Linkage grants in roll forming of metal sheets, and 5 ARC LIEF grants as well as 4 competitive overseas research grants, including 1 Beijing Natural Science Foundation Grant (BNSF) on roll forming and 3 National Natural Science Foundation of China Grants (NFSC) on advanced engineering materials from China. In scientific publication, he has published more than 180 journal/conference papers and confidential reports for industrial partners in his main fields of research - Mechanical Engineering, Materials Engineering, Civil Engineering, etc.

My research interests involves application of Mass Spectrometry based proteomics in Health and Disease especially biomarker discovery and Drug Development. My group uses mass spectrometry based high throughput quantitative proteomics, natural product chemistry, cell biology, animal model, stem cell, and modern biology approach to find the target, to develop novel drugs and elucidate its mode of action against cancer and other metabolic disorders such as diabetes. Cancer is a hyperplastic condition that leads to uncontrolled proliferation, invasion, metastasis, dysregulation of apoptosis and cell cycle. Cancer is the second leading cause of worldwide human mortality after cardiovascular diseases. We are investigating the efficacy of various natural and synthetic metabolites on melanoma, retinoblastoma, leukaemia, and lung cancer using in vitro and in vivo method including animal model. Further, investigating the molecular basis for Cell adhesion, AKT signalling and tyrosine kinase associated cancer progression and response and resistance to targeted therapy in these cancers is in progress in my lab.

Dr. Liakoppolus was born in Athens, Greece in 1968. He received his MD degree from the Aristotle University of Thessaloniki, Greece and PhD degree from the Democritus University of Thrace, Greece. He is currently an Associate Professor of Nephrology at the Division of Nephrology and Hypertension, 1 st Department of Internal Medicine, AHEPA Hospital, Medical School, Aristotle University of Thessaloniki, Greece. Currently, he serves as a member (representing ISN) of the World Kidney Day Steering Committee. Additionally, he is actively involved in many Committees of the Medical School of our University (PhD Committee, MSc Committee, Bioethics Committee, Educational Committee etc) and in the Administration Committee (RESTART) of the Aristotle University of Thessaloniki and is also the Vice-Chairman of the Research Ethics Committee of the University of Peloponnese, Greece.

Dr. Mohammad Amjad Kamal is a Distinguished Adjunct Professor at the King Fahd Medical Research Center (KFMRC), King Abdulaziz University, Jeddah, Saudi Arabia, where he was full Professor from March 2011 to March 2013, and led a highly productive and collaborative research team. Dr. Kamal's biochemical research has culminated in more than 250 publications in internationally respected journals, and 64 abstracts at international conferences. His research involves ongoing collaborations with numerous international scientific teams and, as an example among many successful projects, was pivotal in supporting the development of novel experimental drugs to treat Alzheimer's disease from conception in the laboratory to the clinic with his longtime collaborator Dr. Nigel H. Greig (Chief, Drug Design & Development Section, Translational Gerontology Branch, NIA, NIH, USA).

Dr Kalin Dragnevski obtained his MSc from the University of Chemical Technology & Metallurgy, Sofia, Bulgaria & his PhD from the Institute of Materials at Leeds University. Following a short spell in industry, he took a research position in the Cavendish Laboratory at University of Cambridge. He is now in the Engineering Science Department at the University of Oxford, where he leads the Laboratory for In-situ Microscopy & Analysis (LIMA). His research is aimed at developing methodologies for better understanding the structure-property-composition relationship in advanced materials systems on a micro- & nano-scale using novel in-situ micromechanical testing techniques. His work recently received the prestigious DR Harting Award for best paper of the year, given by the Society of Experimental Mechanics.

Zimei Wu is an Associate Professor at School of Pharmacy, University of Auckland, New Zealand (NZ). She holds a PhD from University of Otago (NZ) and a Masters from China Pharmaceutical University. Her ‘liposomes’ research which has attracted wide collaborations. She received a NZ-China Scientist Exchange Award from the Royal Society of NZ. She also researches transdermal delivery with successful stories featured on NZ TV3.  Zimei also serves on editorial boards of Journal of Liposome Research, and Pharmaceutical Development and Technology and a referee for >20 journals.  Zimei was past President of NZ Local Chapter of Controlled Release Society.

Dr. Kangussu obtained his Ph.D. in Physiology and Pharmacology from the Federal University of Minas Gerais (2014) and then undertook postdoctoral fellowships at the department of Physiology and Biophysics (2017) and Morphology (2019). Currently, he is a full Professor at the department of Morphology of Federal University of Minas Gerais. He has experience in Physiology, Pharmacology and Morphology. More specifically, his research focuses on the following subjects: vasoactive peptides, renin- angiotensin peptides, hypertension, cerebrovascular and neurodegenerative disease.

Dr. Qinlu Lin obtained his Ph.D. degree (in 2002) in Food Science from Hunan Agricultural University and then undertook postdoctoral fellowships at South China University of Technology (2003-2005). He also studied at Lund University in Sweden as a visiting scholar (1999-2000). Currently, he is a full Professor and Dean of the School of Food Science and Engineering of Center South University of Forestry and Technology. He is also the Director of National Engineering Laboratory for Rice and By-product Process. He is experienced in Food Science, Protein Chemistry and Molecular Nutrition. Notably, Dr. Lin has authored more than 300 articles, having over 1000 total citations. In addition, he holds more than 30 patents and has published five academic monographs.

Dr. Runzhi Zhu obtained his Ph.D. degree (in 2010) in Cancer Biology from Shanghai Jiao Tong University, Shanghai, China. He is currently employed as a Professor, in the Center for Cell Therapy, at The Affiliated Hospital of Jiangsu University, Zhenjiang, China. The research of Dr. Zhu is currently focused on Autophagy and Apoptosis in liver injury and cancer therapy, and the roles of PTEN and SPOP in prostate cancer survival and metastasis. Dr. Zhu, as an author/co- author, has published more than 45 articles in various journals, having over 815 total citations.

Dr. A. K. Tiwary is working as Professor (Pharmaceutics) in the Department of Pharmaceutical Sciences & Drug Research at Punjabi University, Patiala, India. He completed his PhD in Pharmaceutics at Birla Institute of Technology, Mesra, Ranchi, India. He has to his credit 113 research papers/articles and one US Patent. His h- index is 30 and i-10 index is 66. He has guided 12 PhD scholars and more than 45 M. Pharm. students. His research pursuits include transdermal drug delivery, modified oral drug delivery using natural polymers and their derivatives, spermicidals, microemulsions and SMEDDS. He actively contributes his expertise to industries, academia and is on the board of many reputed journals as reviewer and editorial board advisor.

Dr. Boris I. Kharisov (born in 1964, in Russia, has lived in Mexico from 1994, and naturalized in Mexico in 2003) is currently a Professor and Researcher at the Universidad Autónoma de Nuevo León (UANL). He took part in the liquidation of the consequences of the Chernobyl accident, working in the contaminated zone in 1987. Degrees: An MS in 1986, in radiochemistry and a PhD in inorganic chemistry in 1993, from the Moscow State University, Russia; Dr. Hab. in physical chemistry in 2006 from Rostov State University, Russia. Memberships: Mexican Academy of Science, National Researchers System (SNI, Level II), Materials Research Society. He is the co-author of nine books, 155 articles, 10 book chapters, and holds four patents. Co-editor: Three invited special issues of international journals. He is the member of the Editorial board of three journals. Specialties: Materials chemistry, coordination and inorganic chemistry, phthalocyanines, ultrasound, nanotechnology, chemical treatment of petroleum, environmental remediation. Dr. Kharisov has three children. His biography was published in: “Who is Who in the World”, “Outstanding People of the Twentieth Century”, and so on.

Changhe Li, Professor, Doctoral supervisor, Famous Teaching Teachers in Shandong Province, Excellent Graduate Guiding Teachers in Shandong Province, Shandong Excellent Inventor, Special Expert of Taishan Scholars. He undertakes three projects of the National Natural Science Foundation, one sub-project of the National 973 Plan, one sub-project of the National Machinery, two key projects of the Shandong Natural Science Foundation and two projects of the Qingdao Science and Technology Development Plan. 153 SCI/EI papers were published by the first author or correspondent, of which more than 50 are Minimum Quantity Lubrication Grinding (MQL) related papers, and 3 are the Highly Cited Papers. Besides, 3 books were published, and 6 invention patents were granted to the United States, South Korea and Australia, and 90 invention patents were granted to China. He has won more than 10 provincial and ministerial awards, such as The Ministry of Education's Second Prize for Technical Invention in Colleges and Universities, Shandong Provincial Second Prize for Technological Invention, The First Prize of Shandong Patent Award, The First Prize of Teaching Achievement in Shandong Province's Colleges and Universities.

Gaetano Gallo is a Researcher at the Department of Medical and Surgical Sciences, University “Magna Græcia”, Catanzaro (Italy). In 2018 he completed a clinical training fellowship in IBD and colorectal tumors at the University of Amsterdam – Academic Medical Center. In 2016 and 2018 he has been awarded a fellowship by the Brazilian Society of Surgical Oncology (BSSO) and by the Japanese Society of Coloproctology (JSCP). His clinical and research interests include haemorrhoidal disease, rectovaginal and perianal fistula fistulas, minimally invasive treatment of pilonidal sinus (EPSiT), rectal prolapse, colorectal tumors and IBD as well as functional pelvic floor diseases. He has also a special interest in translational research (microRNA and microbiome).Since 2017, he is member of the Cohort Studies Committee of European Society of Coloproctology (ESCP) and Y-SICCR (Italian Society of Colorectal Surgery) Chair. Gaetano Gallo has published more than 50 articles in peer-reviewed journals in the field of Colorectal and General Surgery. Moreover, he is also reviewer for the most important european journals in the field of Colorectal Surgery and Proctology.

Dr. Simoes Dos Reis is a materials scientist who holds a Ph.D. in Materials Engineering (2017) and masters and a bachelor's in Environmental engineering. Dr. Simoes Dos Reis has an interest in preparation, and characterization of biomaterials for wastewater treatment, wastes management and reuse, CO2 through carbonation process, etc. In his short scientific career he has published 30 articles and serves as reviewer of 25 international journals.

Gaetano Caramori,MD, PhD, Full Professor in Respiratory Medicine, at the Dipartimento di Scienze Biomediche, Odontoiatriche e delle Immagini Morfologiche e Funzionali (BIOMORF), University of Messina, Italy (www.unime.it). Head of the Pulmonology Unit at the University Hospital Gaetano Martino of Messina, Italy (www.polime.it) and the Specialisation School in Respiratory Diseases of the University of Messina, Italy (www.unime.it). Gaetano Caramori is, from the 2001, Honorary Staff at the Airway Disease Section, National Heart and Lung Institute, Imperial College of London, UK. Gaetano Caramori has reached an H index=46 (www.scopus.com, Author ID:7003847659, http://orcid.org/0000-0002-9807-327X ). He is currently between the 300 Top Italian Scientists & Academics in Clinical Sciences using an independent ranking obtained on the basis of the Google Scholar database (h-index>30only) (http://www.topitalianscientists.org/ TIS_HTML/ Top_ Italian_ Scientists_ Clinical_ Sciences.htm) He has published (http://www.ncbi.nlm.nih.gov/ pubmed) 158 articles in International Scientific peer-reviewed indexed Journals, including all the major Journals of the Respiratory System and The New England Journal of Medicine, The Lancet and Nature Medicine.

Dr. Jelena Popović-Djordjević is a Professor of Organic Chemistry at the University of Belgrade, Faculty of Agriculture (Department for Food Technology and Biochemistry), Belgrade, Serbia. She is a graduate of the University of Belgrade, Faculty of Chemistry, Belgrade, Serbia, where she received her B.A. degree in Chemistry (applied) and her Ph.D. degree in Chemistry (organic) (in 2010). She published over 150 publications, including 40 papers in the leading international peer-reviewed journals, 2 book chapters, and 40 papers on the international and national conferences. Her main research is related to natural product Chemistry, biological activity of natural and synthetic compounds, food chemistry and environmental chemistry. She is a member of the Serbian Chemical Society, the Serbian Water Protection Society, and the Editorial board member in Ecological Safety and Balanced Use of Resources.

Tatjana Stanojković was born in Belgrade on June 26, 1966. She graduated from the Faculty of Biology of the University of Belgrade, Department of Molecular Biology and Physiology. She has been employed at the Institute of Oncology and Radiology of Serbia since 1997, since July 2014, as head of the Department of Biological Response Laboratory, Department of Experimental Oncology. Field of expertise: Experimental oncology, Medicinal Chemistry, in vitro investigation of the anticancer activity of novel synthesized compounds, natural product and marine organisms. Member of the Editorial Board, BMC Complementary and Alternative Medicine since 2012.

Dr. Wu’s current research interests focus on the development of functional polymeric materials for pharmaceutical applications in terms of controllable drug delivery or gene delivery, with over 70 publications on Angew. Chem. Int. Ed., ACS Nano, Adv. Mater., Small, Adv. Healthcare Mater., Biomacromolecules etc and personal H-index of 25 (Google Scholar).

Ewoud-Jan van Hoogdalem, PharmD PhD, is Vice President Global Scientific Affairs in Early Development Services of PRA Health Sciences. He has more than 25 years of drug development experience with small biotech and large pharma companies including JNJ and Yamanouchi (now Astellas). He is board-certified clinical pharmacologist and licensed pharmacist with a PhD from Leiden University. He is member of various professional organizations, co-organizer of various scientific conferences, and is first author/co-author in over 30 publications in peer-reviewed journals or book chapters

Dr Jagajjit Sahu is currently working as a Domain Expert in Manav - Human Atlas Initiative at National Centre for Cell Science, Pune, India. His primary area of expertise is Bioinformatics, especially in the field of genomics and data science. His research interests focus around the improvement and development of genomics approaches. He obtained his Ph.D. from Department of Life Science and Bioinformatics, Assam University, India and post-doctoral research experiences from University of Aberdeen, Banaras Hindu University, and Assam Agricultural University. Dr Sahu has a background in Mathematics, Biotechnology and Bioinformatics. Having more than 9 years of experience, he has been able to publish 27 research articles and a few book chapters. He has presented his research at several international conferences and been acted as a resource person in many workshops.

Dr. Anukool Vaishnav is a Principal Investigator in SERB-National Postdoctoral Fellowship (NPDF) at Department of Mycology and Plant Pathology, Institute of Agricultural Sciences, Banaras Hindu University, Varanasi, India. He obtained his master degree in Biotechnology from University of Rajasthan and Ph.D. in Science (Agri. Microbiology) from Mody University of Science & Technology. He also qualified CSIR- NET (Life science) and ICAR- NET (Agriculture Biotechnology). He has 7 years of research experience in plant-microbe interaction field. His research is mainly focuses on microbial mediated plant protection against biotic and abiotic stress, characterization of signaling molecules and secondary metabolites (soluble and VOCs) in plant holobionts. As an active researcher, he has published more than 30 research and review articles along with several book chapters for reputed journals and edited books. He has filed 9 Indian patents in association with his research group. He has received several awards including best poster award and Young Scientist Award from reputed societies.

Cheng Yang obtained his PhD in 2013 from Fudan University, where he studied the kidney transplantation. During the PhD studying, he visited Prof. Michael Nicholson's lab in Leicester University in UK. After graduation, he focuses on the role of immune system in acute and chronic renal injury, as well as new prevention and treatment strategies. He published more than 40 peer- reviewed papers with over 490 times citations. Cheng Yang received seven awards from American Society of Transplantation and The Transplantation Society from 2012-2018. He is working in Zhongshan Hospital, Fudan University.

Ewoud-Jan van Hoogdalem, PharmD PhD, is Vice President Global Scientific Affairs in Early Development Services of PRA Health Sciences. He has more than 25 years of drug development experience with small biotech and large pharma companies including JNJ and Yamanouchi (now Astellas). He is board-certified clinical pharmacologist and licensed pharmacist with a PhD from Leiden University. He is member of various professional organizations, co-organizer of various scientific conferences, and is first author/co-author in over 30 publications in peer-reviewed journals or book chapters

Francesco Caridi was born in Reggio Calabria, Italy, on December, the 3 rd, 1980. On 2003 he became Master of Science cum laude in Physics at the Messina University, Italy. On 2007 he became Ph.D. in Physics at the Messina University, with excellent final assessment. From July 2007 to December 2008 he was research assistant at the Department of Physics of the Messina University. From December 2008 to June 2014 he was Expert Physicist at the Science Faculty and at the Department of Physics of the Messina University. From July 2014 to today he is PhD researcher at the Agency for Environmental Protection of Calabria, Italy. From the Academic Year 2018-2019 he is Adjunct Professor of Applied Physics at the University of Messina. His research interest includes: lasers; laser-matter interaction; plasma production, diagnostics and applications; environmental radioactivity; gamma-spectrometry;